
|Articles|March 1, 2003
Rx Dilemma
How much is too much to pay for a new dermatological drug? Your answer likely will depend on whether you're a developer or doctor, a patient or a third-party payer. Regardless of one's perspective, it doesn't take a medical degree to recognize the fact that prescription prices have risen precipitously in recent years, a trend which continued in 2002 and is expected to persist well beyond this year.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Transformative Advances This Year and Beyond
2
FDA Proposes Expansion of US Sunscreen Ingredient Standards with Bemotrizinol
3
Phase 3b Study Confirms Ligelizumab’s Consistent CSU Control
4
"PDE4 Inhibitor-Responsive Dermatoses": A Modern Framework for Managing Inflammatory Skin Conditions
5


















